Variable name | HCV negative (n = 167) (%) | HCV positive (n = 198) (%) | OR (95% CI) | p value |
---|---|---|---|---|
Respondent variables | ||||
Years of injection drug use (quartiles) | ||||
0–6 | 81 (48.5) | 20 (10.1) | 1.0 |  |
7–13 | 46 (27.5) | 51 (25.8) | 4.5 (2.4–8.4) | <0.001 |
14–21 | 19 (11.4) | 61 (30.8) | 13.0 (6.4–26.5) | <0.001 |
22–39 | 21 (12.6) | 66 (33.3) | 12.7 (6.4–25.5) | <0.001 |
Gender | Â | Â | Â | Â |
Male | 96 (57.5) | 113 (57.1) | 1.0 | Â |
Female | 71 (42.5) | 85 (42.9) | 1.0 (0.7–1.5) | 0.937 |
Education level | Â | Â | Â | Â |
< grade 12 | 116 (69.5) | 142 (71.7) | 1.0 | Â |
> grade 12 | 51 (30.5) | 56 (28.3) | 0.9 (0.6–1.4) | 0.637 |
Ethnicity | Â | Â | Â | Â |
Caucasian | 71 (42.5) | 57 (28.8) | 1.0 | Â |
Aboriginal | 96 (57.5) | 141 (71.2) | 1.8 (1.2–2.8) | 0.006 |
Moved to Winnipeg in past year | ||||
No | 112 (67.1) | 153 (77.3) | 1.0 | Â |
Yes | 55 (32.9) | 45 (22.7) | 0.6 (0.4–1.0) | 0.030 |
Deals drugs | Â | Â | Â | Â |
No | 85 (50.9) | 107 (54.0) | 1.0 | Â |
Yes | 82 (49.1) | 91 (46.0) | 0.9 (0.6–1.3) | 0.549 |
Cocaine use | Â | Â | Â | Â |
No | 62 (37.1) | 69 (34.9) | 1.0 | Â |
Yes | 105 (62.9) | 129 (65.1) | 1.1 (0.7–1.7) | 0.651 |
Talwin/ritalin use | ||||
No | 134 (80.2) | 113 (57.1) | 1.0 | Â |
Yes | 33 (19.8) | 85 (42.9) | 3.1 (1.9–4.9) | <0.001 |
Morphine use | Â | Â | Â | Â |
No | 110 (65.9) | 121 (61.1) | 1.0 | Â |
Yes | 57 (34.1) | 77 (38.9) | 1.2 (0.8–1.9) | 0.347 |
Heroin use | Â | Â | Â | Â |
No | 145 (86.8) | 184 (92.9) | 1.0 | Â |
Yes | 22 (13.2) | 14 (7.1) | 0.5 (0.2–1.0) | 0.052 |
Injects daily | Â | Â | Â | Â |
No | 20 (12.0) | 43 (21.7) | 1.0 | Â |
Yes | 147 (88.0) | 155 (78.3) | 0.5 (0.3–0.9) | 0.013 |
Injected at a hotel | ||||
No | 109 (65.3) | 107 (54.0) | 1.0 | Â |
Yes | 58 (34.7) | 91 (46.0) | 1.6 (1.0–2.4) | 0.029 |
Injected at a shooting gallery | ||||
No | 153 (91.6) | 156 (78.8) | 1.0 | Â |
Yes | 14 (8.4) | 42 (21.2) | 2.9 (1.5–5.6) | <0.001 |
Ever used someone else's syringe | ||||
No | 90 (53.9) | 49 (24.8) | 1.0 | Â |
Yes | 77 (46.1) | 149 (75.3) | 3.6 (2.3–5.5) | <0.001 |
Injected someone else as a service | ||||
No | 144 (86.2) | 125 (63.1) | 1.0 | Â |
Yes | 23 (13.8) | 73 (36.9) | 3.7 (2.2–6.2) | <0.001 |
Obtains syringes from friends | ||||
No | 50 (29.9) | 73 (36.9) | 1.0 | Â |
Yes | 117 (70.1) | 125 (63.1) | 0.7 (0.5–1.1) | 0.162 |
Obtains syringes from questionable sources | ||||
No | 135 (80.8) | 144 (72.7) | 1.0 | Â |
Yes | 32 (19.2) | 54 (27.3) | 1.6 (1.0–2.6) | 0.067 |
Opposite-sex regular partners | ||||
No | 51 (30.5) | 65 (31.8) | 1.0 | Â |
Yes | 116 (69.5) | 163 (68.2) | 0.9 (0.6–1.4) | 0.640 |
Opposite-sex casual partners | ||||
No | 101 (60.5) | 129 (65.2) | 1.0 | Â |
Yes | 66 (39.5) | 69 (34.9) | 0.8 (0.5–1.3) | 0.357 |
Opposite-sex client partners | ||||
No | 151 (90.4) | 163 (82.3) | 1.0 | Â |
Yes | 16 (9.6) | 35 (17.7) | 2.0 (1.1–3.8) | 0.024 |
Regular same-sex partners | ||||
No | 160 (95.8) | 195 (98.5) | 1.0 | Â |
Yes | 7 (4.2) | 3 (1.5) | 0.4 (0.1–1.4) | 0.116 |
Casual same-sex partners | ||||
No | 160 (95.8) | 191 (96.5) | 1.0 | Â |
Yes | 7 (4.2) | 7 (3.5) | 0.8 (0.3–2.4) | 0.745 |
Client same-sex partners | ||||
No | 163 (97.6) | 194 (98.0) | 1.0 | Â |
Yes | 4 (2.4) | 4 (2.0) | 0.8 (0.2–3.4) | 0.808 |
Egocentric network variables (maximum number of network members = 20) | ||||
Total number of IDU in network | ||||
Median (IQR) | 3 (1,5) | 3 (1,5) | 1.0 (1.0–1.1) | 0.194 |
Total number of IDU family members in network | ||||
Median (IQR) | 0 (0,0) | 0 (0,1) | 1.29 (1.1–1.6) | 0.10 |
Spouse IDU in network | ||||
No | 109 (65.3) | 127 (64.1) | 1.0 | Â |
Yes | 58 (34.7) | 71 (35.9) | 1.1 (0.7–1.6) | 0.822 |
IDU risk network variables (maximum number of IDU = 5) | ||||
Number of IDU respondent sees daily | ||||
None | 54 (32.3) | 66 (33.3) | 1.0 | Â |
1 | 55 (32.9) | 68 (34.3) | 1.0 (0.6–1.7) | 0.964 |
2 | 32 (19.2) | 30 (15.2) | 0.8 (0.4–1.4) | 0.398 |
3–5 | 26 (15.6) | 34 (17.2) | 1.1 (0.6–2.0) | 0.832 |
Number of IDU in network who inject daily | ||||
None | 104 (62.3) | 105 (53.0) | 1.0 | Â |
1 | 32 (19.2) | 36 (18.2) | 1.1 (0.6–1.9) | 0.699 |
2 | 19 (11.4) | 31 (15.7) | 1.6 (0.9–3.0) | 0.137 |
3–5 | 12 (7.2) | 26 (13.1) | 2.1 (1.0–4.5) | 0.042 |
Number of IDU in network who have been IDU for >5 years | ||||
0 | 101 (60.5) | 74 (37.4) | 1.0 | Â |
1 | 28 (16.8) | 40 (20.2) | 1.9 (1.1–3.4) | 0.021 |
2 | 18 (10.8) | 39 (19.7) | 3.0 (1.6–5.6) | 0.001 |
3–5 | 20 (12.0) | 45 (22.7) | 3.1 (1.7–5.6) | <0.001 |
Number of IDU in network who have injected at a hotel | ||||
0 | 117 (70.1) | 112 (56.6) | 1.0 | Â |
1 | 29 (17.4) | 39 (19.7) | 1.4 (0.8–2.4) | 0.222 |
2–5 | 21 (12.6) | 47 (23.7) | 2.3 (1.3–4.2) | 0.004 |
Number of IDU in network who have injected at a shooting gallery | ||||
0 | 134 (80.2) | 143 (72.2) | 1.0 | Â |
1 | 18 (10.8) | 27 (13.6) | 1.4 (0.7–2.7) | 0.298 |
2–5 | 15 (9.0) | 28 (14.1) | 1.7 (0.9–3.4) | 0.102 |
Number of IDU in network with whom respondent has pooled money | ||||
0 | 51 (30.5) | 56 (28.3) | 1.0 | Â |
1 | 42 (25.2) | 54 (27.3) | 1.2 (0.7–2.0) | 0.576 |
2–3 | 43 (25.8) | 55 (27.8) | 1.2 (0.7–2.0) | 0.587 |
4–5 | 31 (18.6) | 33 (16.7) | 1.0 (0.5–1.8) | 0.922 |
Number of IDU in network who have used a syringe before the respondent used it | ||||
0 | 133 (79.6) | 146 (73.7) | 1.0 | Â |
1 | 27 (16.2) | 32 (16.2) | 1.1 (0.6–1.9) | 0.790 |
2–5 | 7 (4.2) | 20 (10.1) | 2.6 (1.1–6.4) | 0.036 |
Number of IDU in network who have used other drug paraphernalia before respondent has used it. | ||||
0 | 105 (62.9) | 119 (60.1) | 1.0 | Â |
1 | 29 (17.4) | 31 (16.7) | 0.9 (0.5–1.7) | 0.841 |
2–5 | 33 (19.8) | 48 (24.2) | 1.3 (0.8–2.1) | 0.342 |
Number of IDU in network who have initiated respondent to injection drug use | ||||
0 | 110 (65.9) | 157 (79.3) | 1.0 | Â |
1 | 48 (28.8) | 35 (17.7) | 0.5 (0.3–0.8) | 0.008 |
2–5 | 9 (5.4) | 6 (3.0) | 0.5 (0.2–1.4) | 0.160 |
Number of IDU in network who have shown respondent how to inject drugs | ||||
0 | 104 (62.3) | 147 (74.2) | 1.0 | Â |
1 | 43 (25.8) | 39 (19.7) | 0.6 (0.4–1.1) | 0.083 |
2–5 | 20 (12.0) | 12 (6.1) | 0.4 (0.2–0.9) | 0.027 |
Number of IDU in network who have injected respondent with drugs | ||||
0 | 89 (53.3) | 88 (44.4) | 1.0 | Â |
1 | 44 (26.4) | 54 (27.3) | 1.2 (0.8–2.0) | 0.392 |
2–5 | 34 (20.4) | 56 (28.3) | 1.7 (1.0–2.8) | 0.054 |
Number of IDU in network who have used talwin/ritalin | ||||
0 | 139 (83.2) | 119 (60.1) | 1.0 | Â |
1–3 | 17 (10.1) | 42 (21.1) | 2.9 (1.6–5.3) | <0.001 |
4–5 | 11 (6.6) | 37 (18.7) | 3.9 (1.9–8.0) | <0.001 |
Number of IDU in network who have used cocaine | ||||
0 | 113 (67.7) | 120 (60.6) | 1.0 | Â |
1 | 23 (13.8) | 36 (18.2) | 1.5 (0.8–2.6) | 0.192 |
2–3 | 17 (10.2) | 30 (15.2) | 1.7 (0.9–3.2) | 0.125 |
4–5 | 14 (8.4) | 12 (6.1) | 0.8 (0.4–1.8) | 0.605 |
Number of IDU in network who have used morphine | ||||
0 | 129 (77.3) | 149 (75.3) | 1.0 | Â |
1 | 22 (13.2) | 31 (15.7) | 1.2 (0.7–2.2) | 0.513 |
2–5 | 16 (9.6) | 18 (9.1) | 1.0 (0.5–2.0) | 0.942 |